Literature DB >> 20144591

The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.

Krzysztof Jozwiak1, Lawrence Toll, Lucita Jimenez, Anthony Yiu-Ho Woo, Rui-Ping Xiao, Irving W Wainer.   

Abstract

The binding thermodynamics of the stereoisomers of fenoterol, (R,R')-, (S,S')-, (R,S')-, and (S,R')-fenoterol, to the beta(2)-adrenergic receptor (beta(2)-AR) have been determined. The experiments utilized membranes obtained from HEK cells stably transfected with cDNA encoding human beta(2)-AR. Competitive displacement studies using [(3)H]CGP-12177 as the marker ligand were conducted at 4, 15, 25, 30 and 37 degrees C, the binding affinities calculated and the standard enthalpic (DeltaH degrees ) and standard entropic (DeltaS degrees ) contribution to the standard free energy change (DeltaG degrees ) associated with the binding process determined through the construction of van't Hoff plots. The results indicate that the binding of (S,S')- and (S,R')-fenoterol were predominately enthalpy-driven processes while the binding of (R,R')- and (R,S')-fenoterol were entropy-driven. All of the fenoterol stereoisomers are full agonists of the beta(2)-AR, and, therefore, the results of this study are inconsistent with the previously described "thermodynamic agonist-antagonist discrimination", in which the binding of an agonist to the beta-AR is entropy-driven and the binding of an antagonist is enthalpy-driven. In addition, the data demonstrate that the chirality of the carbon atom containing the beta-hydroxyl group of the fenoterol molecule (the beta-OH carbon) is a key factor in the determination of whether the binding process will be enthalpy-driven or entropy-driven. When the configuration at the beta-OH carbon is S the binding process is enthalpy-driven while the R configuration produces an entropy-driven process. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144591      PMCID: PMC2850566          DOI: 10.1016/j.bcp.2010.01.035

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.

Authors:  R Seifert; K Wenzel-Seifert; U Gether; B K Kobilka
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

2.  Thermodynamic analysis does not allow discrimination of agonists and antagonists at human CCK2S-receptors.

Authors:  Elaine A Harper; Elizabeth A Mitchell; Eric P Griffin; S Barrett Kalindjian
Journal:  Eur J Pharmacol       Date:  2007-11-28       Impact factor: 4.432

3.  Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

4.  Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.

Authors:  M L Contreras; B B Wolfe; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

Review 5.  Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?

Authors:  P A Borea; A Dalpiaz; K Varani; P Gilli; G Gilli
Journal:  Biochem Pharmacol       Date:  2000-12-01       Impact factor: 5.858

6.  Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.

Authors:  Gayathri Swaminath; Yang Xiang; Tae Weon Lee; Jacqueline Steenhuis; Charles Parnot; Brian K Kobilka
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

7.  Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.

Authors:  Stefania Merighi; Carolina Simioni; Stefania Gessi; Katia Varani; Pier Andrea Borea
Journal:  Biochem Pharmacol       Date:  2009-09-18       Impact factor: 5.858

8.  Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.

Authors:  Anthony Yiu-Ho Woo; Tian-Bing Wang; Xiaokun Zeng; Weizhong Zhu; Darrell R Abernethy; Irving W Wainer; Rui-Ping Xiao
Journal:  Mol Pharmacol       Date:  2008-10-07       Impact factor: 4.436

9.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.

Authors:  K Wieland; H M Zuurmond; C Krasel; A P Ijzerman; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

10.  Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.

Authors:  Krzysztof Jozwiak; Chakir Khalid; Mary J Tanga; Ilona Berzetei-Gurske; Lucita Jimenez; Joseph A Kozocas; Anthony Woo; Weizhong Zhu; Rui-Ping Xiao; Darrell R Abernethy; Irving W Wainer
Journal:  J Med Chem       Date:  2007-05-17       Impact factor: 7.446

View more
  8 in total

1.  {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.

Authors:  L Toll; L Jimenez; N Waleh; K Jozwiak; A Y-H Woo; R-P Xiao; M Bernier; I W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2010-11-11       Impact factor: 4.030

2.  Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.

Authors:  Michael T Reinartz; Solveig Kälble; Irving W Wainer; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-31       Impact factor: 3.000

Review 3.  Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.

Authors:  Krzysztof Jozwiak; Anita Plazinska; Lawrence Toll; Lucita Jimenez; Anthony Yiu-Ho Woo; Rui-Ping Xiao; Irving W Wainer
Journal:  Chirality       Date:  2011-05-26       Impact factor: 2.437

4.  The stereoselective sulfate conjugation of 4'-methoxyfenoterol stereoisomers by sulfotransferase enzymes.

Authors:  Lalitha V Iyer; Anuradha Ramamoorthy; Ewelina Rutkowska; Anna M Furimsky; Liang Tang; Paul Catz; Carol E Green; Krzysztof Jozwiak; Irving W Wainer
Journal:  Chirality       Date:  2012-06-29       Impact factor: 2.437

5.  Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.

Authors:  Lawrence Toll; Karolina Pajak; Anita Plazinska; Krzysztof Jozwiak; Lucita Jimenez; Joseph A Kozocas; Mary J Tanga; James E Bupp; Irving W Wainer
Journal:  Mol Pharmacol       Date:  2012-03-20       Impact factor: 4.436

6.  Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.

Authors:  Anita Plazinska; Wojciech Plazinski; Krzysztof Jozwiak
Journal:  Eur Biophys J       Date:  2015-03-01       Impact factor: 1.733

Review 7.  Structural Insights into Ligand-Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors.

Authors:  Krzysztof Jóźwiak; Anita Płazińska
Journal:  Molecules       Date:  2021-02-06       Impact factor: 4.411

8.  Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.

Authors:  Anita Plazinska; Michal Kolinski; Irving W Wainer; Krzysztof Jozwiak
Journal:  J Mol Model       Date:  2013-09-17       Impact factor: 1.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.